AFP and hepatocellular carcinoma: In the realm of biomarkers, conventional indicators like alpha-fetoprotein (AFP) exhibit limited utility for HCC, with 40–60% sensitivity and 76–96% specificity for diagnosis and even lower accuracy in treatment monitoring (10).